129 related articles for article (PubMed ID: 36075285)
21. The current management and prognosis of acral lentiginous melanoma.
Wells KE; Reintgen DS; Cruse CW
Ann Plast Surg; 1992 Jan; 28(1):100-3. PubMed ID: 1642394
[TBL] [Abstract][Full Text] [Related]
22. A nomogram incorporating Ki67 to predict survival of acral melanoma.
Du Y; Li C; Mao L; Wei X; Bai X; Chi Z; Cui C; Sheng X; Lian B; Tang B; Wang X; Yan X; Li S; Zhou L; Guo J; Si L
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13077-13085. PubMed ID: 37470854
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
[TBL] [Abstract][Full Text] [Related]
24. The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective study.
Sun W; Xu Y; Yang J; Liao Z; Li T; Huang K; Patel P; Yan W; Chen Y
Cancer Commun (Lond); 2020 Nov; 40(11):586-597. PubMed ID: 33025763
[TBL] [Abstract][Full Text] [Related]
25. Depth of invasion analysis to predict acral melanoma outcomes.
Asato MA; Moares-Neto FA; de Toledo Moraes MP; Ocanha-Xavier JP; Takita LC; Marques MEA; Xavier-Júnior JCC
Ann Diagn Pathol; 2024 Apr; 71():152305. PubMed ID: 38640808
[TBL] [Abstract][Full Text] [Related]
26. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
27. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma.
Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Nagarajan P; Curry JL; Ciurea AM; Rubin AI; Hwu WJ; Prieto VG; Aung PP
Arch Pathol Lab Med; 2021 Aug; 145(8):943-952. PubMed ID: 33290520
[TBL] [Abstract][Full Text] [Related]
29. Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system.
Leung AM; Morton DL; Ozao-Choy J; Hari DM; Shin-Sim M; Difronzo AL; Faries MB
JAMA Surg; 2013 Sep; 148(9):879-84. PubMed ID: 23903435
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
[TBL] [Abstract][Full Text] [Related]
31. Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site.
Jung JM; Jung CJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):498-508. PubMed ID: 33871216
[TBL] [Abstract][Full Text] [Related]
32. Predictors of sentinel lymph node status of cutaneous melanoma in Serbian patients.
Jokic S; Markovic I; Bukumiric Z; Jokic V; Rakovic M; Tripkovic J; Stojiljkovic D; Spurnic I; Jevric M; Matic M; Dobrosavljevic D
J BUON; 2018; 23(2):468-474. PubMed ID: 29745094
[TBL] [Abstract][Full Text] [Related]
33. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
34. Is the survival rate for acral melanoma actually worse than other cutaneous melanomas?
Lim Y; Lee J; Lee DY
J Dermatol; 2020 Mar; 47(3):251-256. PubMed ID: 31889335
[TBL] [Abstract][Full Text] [Related]
35. The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultrathick melanomas (≥15 mm in thickness).
El Sharouni MA; Rawson RV; Sigurdsson V; Witkamp AJ; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
J Am Acad Dermatol; 2022 Aug; 87(2):298-305. PubMed ID: 35121073
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors.
Lo SN; Scolyer RA; Thompson JF
Ann Surg Oncol; 2018 Apr; 25(4):894-902. PubMed ID: 29330716
[TBL] [Abstract][Full Text] [Related]
37. Melanoma Thickness and Survival Trends in the United States, 1989 to 2009.
Shaikh WR; Dusza SW; Weinstock MA; Oliveria SA; Geller AC; Halpern AC
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563354
[TBL] [Abstract][Full Text] [Related]
38. Tumor growth rate as a prognostic factor of acral melanoma in a Korean population.
Jo G; Cho SI; Cho Y; Ohn J; Mun JH
Medicine (Baltimore); 2020 May; 99(21):e19936. PubMed ID: 32481257
[TBL] [Abstract][Full Text] [Related]
39. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
40. Metastatic acral lentiginous melanoma in a tertiary referral center in Switzerland: a systematic analysis.
Häfliger EM; Ramelyte E; Mangana J; Kunz M; Kazakov DV; Dummer R; Cheng PF
Melanoma Res; 2018 Oct; 28(5):442-450. PubMed ID: 29847461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]